Australia's largest stock trading and investment forum Australia's #1 stock forum

PER

Click for more information

6.67%

7.0¢ percheron therapeutics limited

For General Information, page-2676

First 2676 Last

Share
Profile

Follow
RYNZN

3,099 Posts.

500

05/09/23

10:34

Post #: 69733461
Share

Originally posted by Atomboi: ↑

I agree there should be Pharma(s) waiting in the wings, but having money in the bank will give us a bit more leverage to say we could self-fund a lot of this.

My ideal outcome would be a partnership instead of a total sale, as the sale at that point would be based on the drug being used for DMD only even though it could possibly be effective in other areas.

Inflammation is the root of soooooo much! DMD is worth around $1B a year - what is the value of the below combined???

Inflammation is associated with diseases such as the following:
- Autoimmune diseases like rheumatoid arthritis
-Cardiovascular diseases like high blood pressure and heart disease
- Gastrointestinal disorders like inflammatory bowel disease
- Lung diseases like asthma
- Mental illnesses like depression
- Metabolic diseases like Type 2 diabetes
- Neurodegenerative diseases like Parkinson’s disease, MS
- Some types of cancer, like colon cancer

Viagra was originally a heart disease drug

Expand

If we get the PRV, we'll sell it and get $150M+ AUD from that. We'll also convert 48c options giving us another $36M AUD. So we'll be sitting on cash of about $200M+.... pretty healthy position to negotiate big bucks from

ANP Price at posting: 6.1¢ Sentiment: Buy Disclosure: Held
18 Upvote

3 Great analysis

Reply

Top Stories

NWH

NRW Holdings voted Wealth Within's hot stock tip

KSN

Mineral Hill transition kicks off for Kingston, gold and silver ramp up to follow

Super PITch gold sponsor RSM Australia: Can Diggers & Dealers 2024 be key to reinvigorating IPO activity?

MTL

Mantle Minerals' Nick Poll talks to HotCopper on finding gold grades up to 3.57g/t at Mt Berghaus

AIZ

Air New Zealand ditches 2030 emissions targets – right as ASIC's Scope 3 reporting changes kick in for FY25

There are more pages in this discussion • 851 more messages in this thread...

First 2676 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 7.0¢		Change -0.005(6.67%)		Mkt cap ! $63.10M

Open	High	Low	Value	Volume
7.5¢	7.5¢	7.0¢	$25.80K	353.7K

Buyers (Bids)

No.	Vol.	Price($)
4	34290	7.0¢

Sellers (Offers)

Price($)	Vol.	No.
7.5¢	63371	2

View Market Depth

No.	Vol.	Price($)
4	34290	0.070
2	28980	0.069
3	33055	0.068
1	9310	0.067
2	15360	0.066

Price($)	Vol.	No.
0.075	63371	2
0.078	75476	2
0.079	175123	2
0.080	287231	3
0.081	25000	1

Last trade - 16.10pm 30/07/2024 (20 minute delay)

PER (ASX) Chart

SPONSORED BY